Vitality Watch

Dossier clinicaltrials observational 25-jun-2026
Human cohort, case-control, or epidemiological association

Sarcopenia Magnetic Resonance Imaging Evaluation (SUSIE)

Key claim: MR Fingerprinting and phosphorus-31 MR spectroscopy are proposed to characterize skeletal muscle in heart-failure patients with sarcopenia via quantitative T1, T2, and post-exercise phosphocreatine recovery profiles.

Abstract

The goal of the proposed research is to investigate Magnetic Resonance (MR) Fingerprinting and P-MRS (Phosphorus-31 MR Spectroscopy) imaging for characterization of skeletal muscle in heart failure patients with sarcopenia. Heart failure patients with and without sarcopenia will be scanned using MR Fingerprinting and an existing Post-exercise phosphocreatine (PCr) recovery MR imaging protocol to obtain characteristic profiles of quantitative T1, T2, and PCr recovery rate.

Why this matters

MR Fingerprinting and phosphorus-31 MR spectroscopy are proposed to characterize skeletal muscle in heart-failure patients with sarcopenia via quantitative T1, T2, and post-exercise phosphocreatine recovery profiles.

Source

Link

Briefing card

Sarcopenia Magnetic Resonance Imaging Evaluation (SUSIE)
Stage: observational · clinicaltrials · 25-jun-2026

MR Fingerprinting and phosphorus-31 MR spectroscopy are proposed to characterize skeletal muscle in heart-failure patients with sarcopenia via quantitative T1, T2, and post-exercise phosphocreatine recovery profiles.

Cross-references (0)

None recorded — doctrine links and citations appear here as scans and citation sweeps find them.

External: nct:NCT04869813

build build 880 · 2bcef25 · 2026-11-18